AA |
Arachidonic acid |
2-AG |
2-Arachidonoylglycerol |
AC |
Adenylate cyclase |
AEA |
Anandamide |
ALT |
Alanine aminotransferase |
ATM |
Adipose tissue macrophage |
BBB |
Blood–brain barrier |
BMI |
Body mass index |
cAMP |
Cyclic adenosine monophosphate |
CB1R |
Cannabinoid-receptor type 1 |
CB2R |
Cannabinoid-receptor type 2 |
CBD |
Cannabidiol |
CBR |
Cannabinoid receptor |
CNS |
Central nervous system |
CRP |
C-reactive protein |
DA |
Dopamine |
DALY |
Disability-adjusted life-years |
DM |
Diabetes mellitus |
DN |
Diabetic nephropathy |
DPN |
Diabetic peripheral neuropathy |
DRP |
Diabetic retinopathy |
EAE |
Experimental autoimmune encephalomyelitis |
ECB |
Endocannabinoid |
ECS |
Endocannabinoid system |
ERK |
Extracellular signal-regulated kinase |
FAAH |
Fatty acid amide hydrolase |
FDA |
Food and Drug Administration |
FR |
Fixed-ratio |
GLUT 4 |
Glucose transporter type 4 |
GPCR |
G-protein-coupled receptor |
GSIS |
Glucose-stimulated insulin secretion |
HbA1C |
Glycated hemoglobin |
HDL |
High-density lipoprotein |
HOMA-IR |
Homeostasis model assessment of insulin resistance |
IDF |
International Diabetes Federation |
IKK-β |
Inhibitor of nuclear factor kappa-B kinase subunit β |
iNOS |
Inducible NO synthase |
IRF5 |
Interferon regulatory factor-5 |
JNK |
c-Jun N-terminal kinase |
MAPK |
Mitogen-activated protein kinase |
MEK |
Mitogen-activated protein kinase kinase |
MNU |
N-Methyl-N-nitrosurea |
NAc |
Nucleus accumbens |
nAChR |
Nicotinic acetylcholine receptor |
NCD |
Non-communicable disease |
NK |
Natural killer |
NLRP3 |
Nucleotide-binding domain and leucine-rich repeat protein 3 |
NSAID |
Non-steroidal anti-inflammatory drug |
PI3K |
Phosphatidylinositol 3-kinase |
PPAR |
Peroxisome proliferator-activated receptor |
PR |
Progressive ratio |
PUFA |
Polyunsaturated fatty acid |
R |
Receptor |
ROS |
Reactive oxygen species |
SC |
Synthetic cannabinoid |
sP |
Sardinian alcohol-preferring |
STRATUS |
Studies with Rimonabant and Tobacco Use |
STZ |
Streptozotocin |
T1DM |
Type 1 diabetes mellitus |
T2DM |
Type 2 diabetes mellitus |
TNF-α |
Tumor necrosis factor-α |
TRPA1 |
Transient receptor potential ankyrin 1 |
TRPV1 |
Transient receptor potential vanilloid 1 |
US |
United States |
VTA |
Ventral tegmental area |
WHO |
World Health Organization |
ZDF |
Zucker diabetic fatty |
γ-GT |
Gamma-glutamyl transferase |
∆8-THCV |
∆8-Tetrahydrocannabivarin |
Δ9-THC |
Δ9-Tetrahydrocannabinol |
AA |
Arachidonic acid |